
Tamoxifen is the most widely prescribed endocrine therapy for breast cancer, with more than 7.5 million woman-years of clinical experience. Tamoxifen has both antiestrogenic and estrogenic activity. The antiestrogenic activity

Your AI-Trained Oncology Knowledge Connection!


Published: February 1st 1997 | Updated: